Overview Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus Status: Recruiting Trial end date: 2025-08-31 Target enrollment: Participant gender: Summary Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus. Phase: Phase 2 Details Lead Sponsor: Biomea Fusion Inc.